tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
David Bouchey

David Bouchey

IFS Securities, Inc
Wall Street Analyst
Ranked #7,631 out of 8,047 Analysts on TipRanks (#20,307 out of 21,521 overall experts)

Success Rate

18%
2 out of 11 Profitable Transactions

Average Return

-29.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied David Bouchey's ratings since 2017 and opened each position for the duration of 1 Year:
18.18% of your transactions would have been profitable with an average return of -29.1%

Stock Rating Distribution

16Ratings
87.50% Buy
12.50% Hold
0.00% Sell
Distribution of David Bouchey's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
CymaBay Therapeutics Inc
(CBAY)
Rating Type:Buy
Dates:Aug 22, 2017 - Aug 22, 2018
Gain:96.20%
The most profitable rating made by David Bouchey

David Bouchey's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
CymaBay Therapeutics
Buy
Reiterated
$13.00
(224.19% Upside)
100%
+96.20%
1
Loxo Oncology
Hold
Downgraded
100%
+42.20%
4
Ocuphire Pharma
Hold
Downgraded
$5.00
(96.85% Upside)
0%
-74.75%
3
Rockwell Med
Buy
Reiterated
$11.00
(497.83% Upside)
0%
-44.24%
8
List of latest recommendations made by David Bouchey. Click to expand and see David Bouchey's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More